Rocket Lab (RKLB) concluded its at-the-market equity offering initiative on Wednesday, issuing 6,726,862 shares that generated gross proceeds of roughly $474 million, prior to deducting commissions and related costs.
Rocket Lab USA, Inc., RKLB
The capital raise operated under a prospectus supplement that was filed on March 17, 2026, which permitted the aerospace firm to issue up to $1 billion worth of shares via at-the-market sales.
In conjunction with the share issuance, Rocket Lab established collared forward contracts for 7,451,200 shares. These arrangements guarantee minimum anticipated proceeds of $474 million, with a maximum potential of roughly $642 million.
These collared forward agreements are scheduled to reach maturity in April 2028. The ultimate proceeds will vary based on whether Rocket Lab opts for early settlement and the specific cap and floor price parameters established in each separate contract.
Rocket Lab indicated it intends to deploy the capital toward expansion opportunities, potential strategic acquisitions, and general operational and working capital requirements. The company did not disclose specific acquisition candidates.
The stock advanced following the announcement, coinciding with broader market gains on Wednesday.
Just prior to the offering’s conclusion, on April 7, Citizens elevated RKLB from Market Perform to Outperform, establishing an $85 price objective.
The investment firm cited Rocket Lab’s launch operations, defense-focused space systems, and what it characterized as a “clearer pathway to higher-value” space-related services as rationale for the rating improvement.
Citizens indicated it views the present valuation as attractive, influenced by a “convergence of multiple strategic and macroeconomic catalysts.” The firm anticipates “meaningful upside opportunity” throughout the coming 12 months and beyond.
The analyst additionally highlighted a favorable geopolitical climate and funding landscape for the space industry as positive factors for the company’s outlook.
The rating upgrade came as Rocket Lab was finalizing a capital raise that surpassed the minimum anticipated threshold outlined in its forward contracts.
The at-the-market framework provides Rocket Lab with enhanced flexibility regarding timing and share pricing, in contrast to traditional offerings that establish a predetermined price point.
This approach enabled the company to execute share sales during periods of market strength, which appears to have been part of the strategy implemented this week.
The collared forward mechanism also establishes a minimum threshold for proceeds, mitigating downside exposure from potential price volatility prior to the April 2028 settlement dates.
Combining the shares already issued with the forward contract commitments, Rocket Lab has secured or committed to raising between approximately $948 million and $1.116 billion in aggregate from this capital program.
The $1 billion offering limit established in the March 17 prospectus has been substantially achieved or surpassed when both elements are combined.
Wednesday’s market close demonstrated investor approval of a capital raise that met — and potentially exceeded — the company’s established objectives.
The post Rocket Lab (RKLB) Stock Jumps 7% Following $474M Capital Raise Completion appeared first on Blockonomi.
